Crystallization Process Development in Drug Manufacturing

This technical report outlines the crystallization process development in drug manufacturing, focusing on the importance of solvent selection and controlled crystallization methods. It describes how Cambrex, a global contract development and manufacturing organization, leverages its expertise to optimize drug substance quality and ensure compliance with regulatory standards. The report details the critical steps involved in crystallization, including identifying operating conditions, evaluating solvent systems, and characterizing the physical properties of active pharmaceutical ingredients (APIs). It emphasizes the significance of controlling nucleation and crystal growth to achieve desired product characteristics. The report also discusses the transition from bench-scale to manufacturing-scale processes, highlighting the role of analytical techniques and modeling studies in ensuring successful technology transfer. By documenting the methodologies employed, the report aims to provide a comprehensive understanding of the crystallization process and its impact on drug development timelines and product quality.